Gabify, a healthtech startup focused on neurodevelopmental care, has raised $175,000 in a pre-seed funding round led by Inflection Point Ventures. The company, founded in 2023 by Sahil Chopra, Prachi Sood, and Vasyl Leshchuk, plans to use the funds for clinical validation, technology advancements, and team expansion.
Gabify’s platform aims to provide early screening and therapy management for speech and neurodevelopmental disorders like autism and ADHD. The platform leverages a dual AI system that combines voice and vision analysis to assess speech patterns, facial expressions, and behavioral indicators based on clinically validated parameters.
The startup’s technology follows a human-in-the-loop approach for clinical validation and has already been deployed across more than 35 preschools and daycare centers, as well as utilized in schools, hospitals, and clinics.
The funding, including Rs 25 lakh from the Nidhi Seed Support Scheme, will help Gabify expand its reach through various models, with a target impact across one million children by 2028. Gabify’s recognition among the top 10 startups under DreamDeal and its participation in Inflection Point Ventures’ IdeaSchool program highlight its potential in the healthtech sector.
Source: Entrackr : Latest Posts